^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    KMT2C mutation

    i
    Other names: MLL3, KMT2C, Lysine Methyltransferase 2C, Histone-Lysine N-Methyltransferase 2C, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 3, Lysine (K)-Specific Methyltransferase 2C, Histone-Lysine N-Methyltransferase, H3 Lysine-4 Specific, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3, Histone-Lysine N-Methyltransferase MLL3, Lysine N-Methyltransferase 2C, ALR-Like Protein, KLEFS2
    Entrez ID:
    58508
    Related biomarkers:
    Mutation
    Others
    KMT2C mutation
    Colorectal Cancer
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Solid Tumor
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Non Small Cell Lung Cancer
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Colorectal Cancer
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Hepatocellular Cancer
    PD1 inhibitor + lenvatinib
    Sensitive
    :
    C3
    KMT2C mutation
    Renal Cell Carcinoma
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Melanoma
    Immunotherapy
    Sensitive
    :
    C3
    KMT2C mutation
    Bladder Cancer
    Immunotherapy
    Sensitive
    :
    C3